These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 3279111)

  • 21. Circulating antibodies against the breast tumor marker GCDFP-15/gp17 in mammary carcinoma patients and in patients carrying benign breast conditions.
    Pasquinelli R; Barba P; Capasso I; D'Aiuto M; D'Aiuto G; Anzisi AM; De Berardinis P; Guardiola J
    Int J Cancer; 1999 Dec; 84(6):568-72. PubMed ID: 10567900
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunoperoxidase staining for tumor markers in patients with carcinoma of the breast.
    Cox CE; Haagensen DE; Dilley WG; Wells SA
    Surg Forum; 1978; 29():160-2. PubMed ID: 401405
    [No Abstract]   [Full Text] [Related]  

  • 23. Comparative study of monoclonal antibody B72.3 and gross cystic disease fluid protein-15 as markers of apocrine carcinoma of the breast.
    Honma N; Takubo K; Arai T; Younes M; Kasumi F; Akiyama F; Sakamoto G
    APMIS; 2006 Oct; 114(10):712-9. PubMed ID: 17004974
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PIP/GCDFP-15 gene expression and apocrine differentiation in carcinomas of the breast.
    Pagani A; Sapino A; Eusebi V; Bergnolo P; Bussolati G
    Virchows Arch; 1994; 425(5):459-65. PubMed ID: 7850069
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatic clearance and metabolism in the rat of a human breast cancer associated glycoprotein (GCDFP-15).
    Toth CA; Haagensen DE; Davis S; Zamcheck N; Thomas P
    Breast Cancer Res Treat; 1988 Oct; 12(2):235-43. PubMed ID: 3242652
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunohistochemical localization of gross cystic disease fluid protein-15, -24 and -44 in ductal carcinoma in situ of the breast: relationship to the degree of differentiation.
    Selim AA; El-Ayat G; Wells CA
    Histopathology; 2001 Aug; 39(2):198-202. PubMed ID: 11493337
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Breast gross cystic disease protein 15 in human breast cancer in culture.
    Miller WR; Shivas AA; Franchimont P; Haagensen DE
    Eur J Cancer Clin Oncol; 1988 Feb; 24(2):223-8. PubMed ID: 3356211
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Breast cyst fluid proteins and breast cancer.
    Zangerle PF; Spyratos F; Le Doussal V; Noel G; Hacene K; Hendrick JC; Gest J; Franchimont P
    Ann N Y Acad Sci; 1986; 464():331-49. PubMed ID: 3089095
    [TBL] [Abstract][Full Text] [Related]  

  • 29. E-cadherin immunohistochemical analysis of histiocytoid carcinoma of the breast.
    Gupta D; Croitoru CM; Ayala AG; Sahin AA; Middleton LP
    Ann Diagn Pathol; 2002 Jun; 6(3):141-7. PubMed ID: 12089723
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mitogenic effect of the 15-kDa gross cystic disease fluid protein (GCDFP-15) on breast-cancer cell lines and on immortal mammary cells.
    Cassoni P; Sapino A; Haagensen DE; Naldoni C; Bussolati G
    Int J Cancer; 1995 Jan; 60(2):216-20. PubMed ID: 7829219
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assay of GCDFP-15 by ELISA: an available method for in vitro studies of functional differentiation in human breast cancer.
    Revillion-Carette F; Hornez L; Vandewalle B; Lefebvre J
    Tumori; 1988 Dec; 74(6):669-74. PubMed ID: 3232212
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gross cystic disease fluid protein-15 reactivity in extramammary Paget's disease with and without associated internal malignancy.
    Kohler S; Smoller BR
    Am J Dermatopathol; 1996 Apr; 18(2):118-23. PubMed ID: 8739985
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An immunohistochemical study of the tissue distribution of the breast cyst fluid protein, zinc alpha 2 glycoprotein.
    Bundred NJ; Miller WR; Walker RA
    Histopathology; 1987 Jun; 11(6):603-10. PubMed ID: 3305282
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Presence of alpha-lactalbumin, epidermal growth factor, epithelial membrane antigen, and gross cystic disease fluid protein (15,000 daltons) in breast cyst fluid.
    Collette J; Hendrick JC; Jaspar JM; Franchimont P
    Cancer Res; 1986 Jul; 46(7):3728-33. PubMed ID: 3486713
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of apocrine differentiation markers in neuroendocrine breast carcinomas of aged women.
    Sapino A; Righi L; Cassoni P; Papotti M; Gugliotta P; Bussolati G
    Mod Pathol; 2001 Aug; 14(8):768-76. PubMed ID: 11504836
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Review of GCDFP-15. An apocrine marker protein.
    Haagensen DE; Dilley WG; Mazoujian G; Wells SA
    Ann N Y Acad Sci; 1990; 586():161-73. PubMed ID: 2192632
    [No Abstract]   [Full Text] [Related]  

  • 37. Alpha-lactalbumin and GCDFP-15 as breast tumor markers (an opportunity to study breast tumors functionally).
    Collette J; Van Cauwenberge JR; Le Doussal V; Serilas M; Hustin J; Carlisi A; Dejardin L; Franchimont P
    Int J Rad Appl Instrum B; 1987; 14(4):385-95. PubMed ID: 3654256
    [No Abstract]   [Full Text] [Related]  

  • 38. Cytology of pleomorphic lobular carcinoma with apocrine cell differentiation of the breast. A case report.
    Tashiro T; Hirokawa M; Iuchi K; Emoto K; Tanaka T; Monobe Y; Sano T
    Acta Cytol; 2003; 47(2):265-9. PubMed ID: 12685199
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Syringocystadenoma papilliferum of the male breast.
    Nowak M; Pathan A; Fatteh S; Fatteh S; Lopez J
    Am J Dermatopathol; 1998 Aug; 20(4):422-4. PubMed ID: 9700386
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Value of GCDFP-15 (BRST-2) as a specific immunocytochemical marker for breast carcinoma in cytologic specimens.
    Fiel MI; Cernaianu G; Burstein DE; Batheja N
    Acta Cytol; 1996; 40(4):637-41. PubMed ID: 8693878
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.